• Products Overview
• Product List
• Stan S41
• Goldtrace
• Mounting Solutions
• ST Analysis
  • CMS with ST
  • Clinical
    • Clinical Evidence
    • Client References
    • Summaries & Abstracts
    • Clinical Bibliography
      • Meta-analysis
      • Randomized controlled trials
      • Observational studies
      • Cost effectiveness studies
      • Reviews
      • Letter to the Editor
      • Other
• Product Material and Brochures

Letter to the Editor

2016 – Vayssière et al.
Vayssière et al. (2016) Is STAN monitoring associated with a significant decrease in metabolic acidosis at birth compared with cardiotocography alone? Review of the three meta-analyses that included the recent US trial. Acta Obstet Gynecol Scand. 2016 June 6. doi: DOI: 10.1111/aogs.12923

2016 – Kessler et al.
Kessler et al. (2016) Biphasic ST should not be omitted from STAN clinical guidelines. Acta Obstet Gynecol Scand. 2016 Jan;95(1):116. doi: 10.1111/aogs.12776. Epub 2015 Oct 14

2016 – Kessler et al.
Kessler et al. (2016), Why did the authors perform a meta-analysis of studies with primary endpoints they consider clinically unimportant? Acta Obstet Gynecol Scand. 2016 Feb 16. doi: 10.1111/aogs.12876. (Epub ahead of print)

2016 – Gucciardo et al.
Letter to the Editor – New England Journal of Medicine

2016 – Olofsson, P.
Olofsson, P. (2016), Belittling of a significant decline in neonatal metabolic acidosis rate achieved by STAN monitoring. Acta Obstetricia et Gynecologica Scandinavica. doi: 10.1111/aogs.12861